The 12 closest competitors and alternatives to Mercy BioAnalytics, Inc. among biotechnology companies — ranked by similarity to what Mercy BioAnalytics, Inc. actually does, not by market-cap band.
Subscribe to see Mercy BioAnalytics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Mercy BioAnalytics, Inc. is a privately held biotechnology company founded in 2018 and headquartered in Waltham, Massachusetts. The company is dedicated to developing early diagnostics and detection technologies.
Mercy BioAnalytics, Inc. is a biotechnology company headquartered in United States. It has raised at least $127.3M across the 3 funding rounds on record. Its most recent funding round, Series B, raised $59M in September 2025. Xcout tracks 1 named person at Mercy BioAnalytics, Inc., including Dawn Mattoon (Chief Executive Officer).
At least $127.3M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $59M | 13 named | |
| Series B | $41M | 12 named | |
| SEC Form D filing | $27.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Mercy BioAnalytics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Diagnostics
Naveris, Inc. is a biotechnology research and cancer detection company located in Waltham, Massachusetts. It specializes in developing advanced molecular diagnostic blood tests for HPV-associated cancers.
Similar biotechnology company
Biological Dynamics, Inc. is a healthcare company committed to improving global health outcomes by detecting diseases in their earliest stages.
Biotech
As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.
Diagnostics
Exosome Diagnostics, Inc. is a molecular diagnostics company located in Massachusetts, United States. The company specializes in developing biofluid-based liquid biopsy tests, such as the ExoDx Prostate test, for use in personalized medicine and oncology.
Similar biotechnology company
Day Zero Diagnostics, Inc. is a Boston-based company founded in 2016 that is pioneering a new class of infectious disease diagnostics using whole-genome sequencing and machine learning to address antibiotic resistance.
Molecular Diagnostics
Molecular Stethoscope, Inc. develops clinical-grade diagnostic products and services, establishing corporate headquarters and research and development laboratories in South San Francisco.
Similar biotechnology company
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Healthcare
EarlyDiagnostics, also known as EarlyDx, is a clinical-stage precision diagnostics company that develops non-invasive liquid biopsy technologies and genomics platforms for early cancer detection.
Healthcare
AOA Dx Inc. is a US-based diagnostics biotechnology company with offices in Boston, New York, and London, focusing on the early detection of ovarian cancer.
Similar biotechnology company
Molecular Loop Biosciences, Inc. is a genomics and targeted sequencing leader headquartered in Woburn, Massachusetts, founded in 2018 to advance molecular biology tools.
Biotechnology & Healthcare
Liquid BioScience, Inc. is a biotechnology company operating within the United States, focusing on advanced analytics and diagnostics in the biotech sector.
Similar biotechnology company
Biobot Analytics, Inc. is a for-profit biotechnology company based in Cambridge, Massachusetts, known as a leader in wastewater epidemiology and public health analytics.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Mercy BioAnalytics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →